Fig. 2From: Rosuvastatin improves endothelial function in patients with inflammatory joint diseases, longitudinal associations with atherosclerosis and arteriosclerosis: results from the RORA-AS statin intervention studyMean brachial artery diameter plotted against time at baseline and study end. Flow-mediated vasodilation (FMD) mean brachial artery diameter (millimeters) plotted against time (seconds) in patients with inflammatory joint diseases and established atherosclerosis (n = 85), before and after 18 months of rosuvastatin treatmentBack to article page